Prevention of Pneumocystis carinii pneumonia: Who are we missing?

被引:15
|
作者
Schwarcz, SK
Katz, MH
Hirozawa, A
Gurley, J
Lemp, GF
机构
[1] S. Francisco Dept. Pub. Hlth., E., San Francisco, CA
[2] S. Francisco Dept. Pub. Hlth., E., San Francisco, CA 94102
关键词
Pneumocystis carinii pneumonia; chemoprophylaxis; HIV; AIDS; health-care utilization; cost;
D O I
10.1097/00002030-199710000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To obtain population-based information on the characteristics of persons who were not receiving chemoprophylaxis against Pneumocystis carinii pneumonia (PCP) by examining the use of primary and secondary PCP prophylaxis among San Francisco residents whose AIDS-defining opportunistic illness was PCP in 1993. Design: Retrospective medical record review. Setting: Medical charts were obtained From San Francisco hospitals and outpatient facilities at which AIDS patients received their initial AIDS diagnosis. Participants: San Francisco residents whose AIDS-defining opportunistic illness was PCP in 1993. Main outcome measures: Use of primary and secondary PCP prophylaxis. Results: Of the 326 eligible patients, 35% received primary PCP prophylaxis. Nonwhites were significantly less likely to have received primary PCP prophylaxis than white patients [22 versus 40%, respectively; odds ratio (OR), 0.49195% confidence intervals (CI), 0.28-0.87]. Uninsured individuals were also less likely to have received primary PCP prophylaxis than those with insurance (18 versus 41%, OR, 0.35; 95% Cl, 0.17-0.73). The sociodemographic characteristics of patients who did and did not receive secondary PCP prophylaxis did not differ significantly. The most frequently cited reasons for not receiving primary PCP prophylaxis were that patients were unaware of their infection with HIV or were not receiving regular medical care. Conclusions: Barriers to receipt of PCP prophylaxis exist and are resulting in cases of preventable disease and unnecessary medical costs. Interventions to increase counseling, testing, and referral to medical care for pet-sons at high risk for HIV infection are needed.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [11] The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia
    Teira, R
    Virosta, M
    Muñoz, J
    Zubero, Z
    Santamaría, JM
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (06) : 595 - 596
  • [12] PNEUMOCYSTIS CARINII PNEUMONIA
    REMINGTON, JS
    GENTRY, LO
    JOURNAL OF PEDIATRICS, 1971, 78 (01): : 182 - +
  • [13] PNEUMOCYSTIS CARINII PNEUMONIA
    FALKENBACH, K
    BACHMANN, KD
    OLOUGHLIN, BJ
    AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1961, 85 (04): : 706 - &
  • [14] Pneumocystis carinii Pneumonia
    Hsu, Yung-Hsiang
    TZU CHI MEDICAL JOURNAL, 2007, 19 (03): : 179 - 180
  • [15] PNEUMOCYSTIS CARINII PNEUMONIA
    SETHI, KK
    LANCET, 1967, 1 (7504): : 1387 - &
  • [16] PNEUMOCYSTIS CARINII PNEUMONIA
    MARSHALL, WC
    FRENKEL, JK
    LANCET, 1966, 1 (7428): : 94 - &
  • [17] PNEUMOCYSTIS CARINII PNEUMONIA
    CAPITANI.MA
    KIRKPATR.JA
    AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1966, 97 (01): : 174 - &
  • [18] PNEUMOCYSTIS CARINII PNEUMONIA
    不详
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 194 (10): : 1129 - &
  • [19] Pneumocystis carinii pneumonia
    Mahomed, AG
    Richards, GA
    Feldman, C
    SOUTH AFRICAN MEDICAL JOURNAL, 2000, 90 (07): : 658 - 658
  • [20] PNEUMOCYSTIS CARINII PNEUMONIA
    ROWE, CW
    RADIOLOGY, 1960, 75 (02) : 257 - 261